2.975 USD
-0.13 (-4.34%)
Overall AGEN gets a fundamental rating of 2 out of 10. We evaluated AGEN against 525 industry peers in the Biotechnology industry. AGEN may be in some trouble as it scores bad on both profitability and health. AGEN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- AGEN had negative earnings in the past year.
- AGEN had a negative operating cash flow in the past year.
- In the past 5 years AGEN always reported negative net income.
- In the past 5 years AGEN reported 4 times negative operating cash flow.
1.2 Ratios
- AGEN's Return On Assets of -15.13% is fine compared to the rest of the industry. AGEN outperforms 79.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.13% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-77.38%
ROA(5y)-64.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of AGEN (98.93%) is better than 98.29% of its industry peers.
- AGEN's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for AGEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 98.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- AGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AGEN has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for AGEN has been increased compared to 5 years ago.
- Compared to 1 year ago, AGEN has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -14.09, we must say that AGEN is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -14.09, AGEN is not doing good in the industry: 78.48% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -14.09 |
ROIC/WACCN/A
WACC5.91%
2.3 Liquidity
- AGEN has a Current Ratio of 0.47. This is a bad value and indicates that AGEN is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.47, AGEN is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
- A Quick Ratio of 0.47 indicates that AGEN may have some problems paying its short term obligations.
- AGEN has a Quick ratio of 0.47. This is amonst the worse of the industry: AGEN underperforms 89.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 81.05% over the past year.
- Looking at the last year, AGEN shows a very negative growth in Revenue. The Revenue has decreased by -33.41% in the last year.
- AGEN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.17% yearly.
EPS 1Y (TTM)81.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.99%
Revenue 1Y (TTM)-33.41%
Revenue growth 3Y-29.53%
Revenue growth 5Y-7.17%
Sales Q2Q%20.4%
3.2 Future
- The Earnings Per Share is expected to grow by 15.41% on average over the next years. This is quite good.
- AGEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.37% yearly.
EPS Next Y91.44%
EPS Next 2Y46.39%
EPS Next 3Y22.51%
EPS Next 5Y15.41%
Revenue Next Year0.26%
Revenue Next 2Y29.88%
Revenue Next 3Y4.37%
Revenue Next 5Y16.37%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Based on the Price/Forward Earnings ratio of 1.95, the valuation of AGEN can be described as very cheap.
- Based on the Price/Forward Earnings ratio, AGEN is valued cheaply inside the industry as 99.62% of the companies are valued more expensively.
- AGEN is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.83, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1.95 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as AGEN's earnings are expected to grow with 22.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.39%
EPS Next 3Y22.51%
5. Dividend
5.1 Amount
- AGEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AGENUS INC / AGEN FAQ
Can you provide the ChartMill fundamental rating for AGENUS INC?
ChartMill assigns a fundamental rating of 2 / 10 to AGEN.
Can you provide the valuation status for AGENUS INC?
ChartMill assigns a valuation rating of 4 / 10 to AGENUS INC (AGEN). This can be considered as Fairly Valued.
What is the profitability of AGEN stock?
AGENUS INC (AGEN) has a profitability rating of 2 / 10.
Can you provide the financial health for AGEN stock?
The financial health rating of AGENUS INC (AGEN) is 0 / 10.
Can you provide the dividend sustainability for AGEN stock?
The dividend rating of AGENUS INC (AGEN) is 0 / 10 and the dividend payout ratio is 0%.